Jaguar Health (NASDAQ: JAGX) reported Q2 EPS of ($15.68), $36.47 better than the analyst estimate of ($52.15). Revenue for the quarter came in at $1.23 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Jaguar Health (JAGX) click here.